Literature DB >> 17055456

The interaction of hepatitis B virus X protein and protein phosphatase type 2 Calpha and its effect on IL-6.

Ji Su Kim1, Bo young Rho, Tae Ho Lee, Jae Myun Lee, Se Jong Kim, Jeon Han Park.   

Abstract

HBx has been suggested as an important determinant mediating the pathological effects of HBV via interacting with various cellular proteins. To identify new HBx-interacting proteins and elucidate a possible mechanism associated with HBx and HBx-interacting proteins in hepatocellular carcinoma, yeast two-hybrid screening was performed. We identified a novel HBx-interacting protein, serine/threonine protein phosphatase PP2Calpha, and investigated the effects of PP2Calpha on HBx-mediated IL-6 regulation. The interaction between endogenous PP2Calpha, and HBx was confirmed by co-immunoprecipitation. Recombinant HBx dose-dependently reduced enzyme activity of recombinant PP2Calphain vitro. While ectopically expressed PP2Calpha in Cos-7 and Huh-7 cells reduced the expression of IL-6, overexpressed HBx with recombinant HBx-expressing adenovirus overcame PP2Calpha-mediated IL-6 downregulation. In the response of IL-6, HBx phosphorylated STAT3 and recovered PP2Calpha-mediated dephosphorylation of STAT3. These results supported that HBx might play a crucial role in HBV-associated hepatocarcinogenesis even in cases where cells express a negative regulator, PP2Calpha.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055456     DOI: 10.1016/j.bbrc.2006.10.028

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  PPM1A is a RelA phosphatase with tumor suppressor-like activity.

Authors:  X Lu; H An; R Jin; M Zou; Y Guo; P-F Su; D Liu; Y Shyr; W G Yarbrough
Journal:  Oncogene       Date:  2013-07-01       Impact factor: 9.867

2.  HBV X gene transfection upregulates IL-1beta and IL-6 gene expression and induces rat glomerular mesangial cell proliferation.

Authors:  Hongzhu Lu; Jianhua Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-06-19

3.  Hepatitis B Virus Middle Protein Enhances IL-6 Production via p38 MAPK/NF-κB Pathways in an ER Stress-Dependent Manner.

Authors:  Yang-Xia Li; Yan-Li Ren; Hai-Jing Fu; Ling Zou; Ying Yang; Zhi Chen
Journal:  PLoS One       Date:  2016-07-19       Impact factor: 3.240

4.  The Relationship Between Serum Interleukin-6 and the Recurrence of Hepatitis B Virus Related Hepatocellular Carcinoma after Curative Resection.

Authors:  Tao Sheng; Bin Wang; Shu-Yun Wang; Biao Deng; Lei Qu; Xiao-Sheng Qi; Xiao-Liang Wang; Gui-Long Deng; Xing Sun
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

Review 5.  Regulation of Pattern-Recognition Receptor Signaling by HBX During Hepatitis B Virus Infection.

Authors:  Hongjuan You; Suping Qin; Fulong Zhang; Wei Hu; Xiaocui Li; Dongsheng Liu; Fanyun Kong; Xiucheng Pan; Kuiyang Zheng; Renxian Tang
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

6.  Hepatitis B virus X protein binding to hepsin promotes C3 production by inducing IL-6 secretion from hepatocytes.

Authors:  Mingming Zhang; Jianxin Gu; Chunyi Zhang
Journal:  Oncotarget       Date:  2016-02-16

7.  CRISPR/Cas9-mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV-positive hepatocellular carcinoma cells.

Authors:  Jia Song; Xiaochao Zhang; Qianyun Ge; Chaoyi Yuan; Liang Chu; Hui-Fang Liang; Zhibin Liao; Qiumeng Liu; Zhanguo Zhang; Bixiang Zhang
Journal:  J Cell Biochem       Date:  2018-06-15       Impact factor: 4.429

8.  Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.

Authors:  Marissa M Minor; F Blaine Hollinger; Adrienne L McNees; Sung Yun Jung; Antrix Jain; Joseph M Hyser; Karl-Dimiter Bissig; Betty L Slagle
Journal:  Cells       Date:  2020-03-30       Impact factor: 6.600

Review 9.  A Pleiotropic Role of the Hepatitis B Virus Core Protein in Hepatocarcinogenesis.

Authors:  Caroline Lefeuvre; Hélène Le Guillou-Guillemette; Alexandra Ducancelle
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.